Point of Care Lipid Test Market: Size, Share, Competitive Landscape, and Trend Analysis
The global point of care lipid test market was valued at $284.9 million in 2021 and is projected to reach $426.6 million by 2031, growing at a CAGR of 4.1% from 2022 to 2031. Point of care testing (POCT) provides real-time, lab-quality diagnostic data for healthcare professionals. Utilizing immunoassays and lateral flow chromatography, POCT devices evaluate whole blood. Applications include drug abuse screening, pregnancy testing, fecal occult blood analysis, rapid coagulation testing, blood gas and electrolytes analysis, and rapid cardiac markers diagnosis.